Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7QFV

Crystal structure of KLK6 in complex with compound 17a

これはPDB形式変換不可エントリーです。
7QFV の概要
エントリーDOI10.2210/pdb7qfv/pdb
関連するPDBエントリー7QFT
分子名称Kallikrein-6, KLK6 Activity-Based Probe (Ahx-DPhe-Ser(Z)-Dht-Arg-DPP) (3 entities in total)
機能のキーワードserine proteases, peptide binding protein
由来する生物種Homo sapiens (human)
詳細
タンパク質・核酸の鎖数4
化学式量合計50813.65
構造登録者
Jagtap, P.K.A.,Zhang, L.,De Vita, E.,Tate, E.W.,Hennig, J. (登録日: 2021-12-06, 公開日: 2022-10-26, 最終更新日: 2024-01-31)
主引用文献Zhang, L.,Lovell, S.,De Vita, E.,Jagtap, P.K.A.,Lucy, D.,Goya Grocin, A.,Kjaer, S.,Borg, A.,Hennig, J.,Miller, A.K.,Tate, E.W.
A KLK6 Activity-Based Probe Reveals a Role for KLK6 Activity in Pancreatic Cancer Cell Invasion.
J.Am.Chem.Soc., 144:22493-22504, 2022
Cited by
PubMed Abstract: Pancreatic cancer has the lowest survival rate of all common cancers due to late diagnosis and limited treatment options. Serine hydrolases are known to mediate cancer progression and metastasis through initiation of signaling cascades and cleavage of extracellular matrix proteins, and the kallikrein-related peptidase (KLK) family of secreted serine proteases have emerging roles in pancreatic ductal adenocarcinoma (PDAC). However, the lack of reliable activity-based probes (ABPs) to profile KLK activity has hindered progress in validation of these enzymes as potential targets or biomarkers. Here, we developed potent and selective ABPs for KLK6 by using a positional scanning combinatorial substrate library and characterized their binding mode and interactions by X-ray crystallography. The optimized KLK6 probe IMP-2352 (/ = 11,000 M s) enabled selective detection of KLK6 activity in a variety of PDAC cell lines, and we observed that KLK6 inhibition reduced the invasiveness of PDAC cells that secrete active KLK6. KLK6 inhibitors were combined with N-terminomics to identify potential secreted protein substrates of KLK6 in PDAC cells, providing insights into KLK6-mediated invasion pathways. These novel KLK6 ABPs offer a toolset to validate KLK6 and associated signaling partners as targets or biomarkers across a range of diseases.
PubMed: 36413626
DOI: 10.1021/jacs.2c07378
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.56 Å)
構造検証レポート
Validation report summary of 7qfv
検証レポート(詳細版)ダウンロードをダウンロード

227344

件を2024-11-13に公開中

PDB statisticsPDBj update infoContact PDBjnumon